About
CorRen is developing an autonomous, hands-free Ankle Brachial Index (ABI) test for detecting Peripheral Artery Disease (PAD). The worldwide market potential for ABI testing equipment stands at $1.6B. Existing ABI testing methods face challenges of complexity and time constraints. CorRen's UltraSense is designed to bridge this gap, providing an accurate, user-friendly, and reimbursable solution that has the potential to revolutionize PAD diagnosis and treatment.
Technologies
Outlook
Blue Host
Google Font API
Nginx
Mobile Friendly
Google Tag Manager
Apache
reCAPTCHA
WordPress.org
Keywords
medical equipment manufacturing
low flow detection
reliable ultrasound
healthcare technology
ultrasound system
diagnostic accuracy
procedure efficiency
medical imaging software
stochastic resonance ultrasound
clinical diagnostics
medical staff training
signal boosting
hands-free ultrasound
disruptive ultrasound innovation
vessel location
medical device development
vascular disease detection
automated vessel localization
signal enhancement
telemedicine
medical device
ultrasound signal analysis
medical device innovation
diagnostic report
ultrasound signal amplification
ai-driven pad screening
cost reduction
medical devices
medical equipment and supplies manufacturing
healthcare analytics
Company Information
-
Employees 7
-
Founded 2022
Location
Loma Linda, California, United States
